Publication: miR-21 promotes dengue virus serotype 2 replication in HepG2 cells
Issued Date
2017-06-01
Resource Type
ISSN
18729096
01663542
01663542
Other identifier(s)
2-s2.0-85016488321
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antiviral Research. Vol.142, (2017), 169-177
Suggested Citation
Sitthichai Kanokudom, Tirayut Vilaivan, Nitwara Wikan, Chutima Thepparit, Duncan R. Smith, Wanchai Assavalapsakul miR-21 promotes dengue virus serotype 2 replication in HepG2 cells. Antiviral Research. Vol.142, (2017), 169-177. doi:10.1016/j.antiviral.2017.03.020 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/42787
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
miR-21 promotes dengue virus serotype 2 replication in HepG2 cells
Other Contributor(s)
Abstract
© 2017 Elsevier B.V. Infection with the mosquito transmitted dengue virus (DENV) remains a significant worldwide public health problem. While the majority of infections are asymptomatic, infection can result in a range of symptoms. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through repression or degradation of mRNAs. To understand the contribution of miRNAs to DENV 2 replication, we screened a number of candidate miRNAs for variations in expression levels during DENV 2 infection of HepG2 (liver) cells. Seven miRNAs were identified as differentially expressed, and one, miR-21, was differentially expressed at all time points examined. Interestingly, miR-21 was also differentially regulated in DENV 2 infection under conditions of antibody dependent enhancement of infection, and in direct Zika virus infection, but not in DENV 4 infection. The role of miR-21 during DENV infection was further examined by treating HepG2 cells with an anti-miR-21 (AMO-21) before DENV infection. The results showed a significant reduction in DENV 2 production, clearly suggesting that miR-21 plays a key role in DENV 2 replication. To further confirm the role of miR-21 in DENV infection, a peptide nucleic acid-21 (PNA-21) construct with a nucleotide sequence complementary to AMO-21, was co-administered with AMO-21 as an AMO-21/PNA-21 complex followed by DENV 2 infection. The results showed that AMO-21 significantly reduced DENV 2 titer, PNA-21 significantly increased DENV 2 titer and the combined AMO-21/PNA-21 showed no difference from non-treated infection controls. Taken together, the results show that miR-21 promotes DENV 2 replication, and this mechanism could serve as a possible therapeutic intervention point.